OBJECTS: MicroRNAs have been found in the developing central nervous system, but little is known about their functions in development, especially in the abnormal development of spinal cord in spina bifida. To this end, we have studied the mechanism of microRNAs involved in the morphogenesis of the spinal cord in all-trans-retinoic acid (RA)-treated spina bifida rat fetus. MATERIALS AND METHODS: Timed-pregnant rats were gavage-fed RA, and embryos were obtained on 13.5, 15.5, 17.5, and 19.5 days. MicroRNAs' expression profile was analyzed by Northern blot. In situ apoptosis detection and microRNA in situ hybridization methods on sections of paraffin-embedded tissues were employed to explore the mechanism. CONCLUSION: Administration of RA reduced the size of the spinal cord, probably as a consequence of increased cell death. There is a dramatic decrease in the expression of miR-9/9*, miR-124a and miR-125b, and Bcl2 and P53 as well in the sacral cord from E13.5 to E19.5 days post coitum. Our data showed that expression of these microRNAs was dysregulated in RA-treated spinal cord during embryonic development, suggesting that they may be involved in the development of the spinal cord.
OBJECTS: MicroRNAs have been found in the developing central nervous system, but little is known about their functions in development, especially in the abnormal development of spinal cord in spina bifida. To this end, we have studied the mechanism of microRNAs involved in the morphogenesis of the spinal cord in all-trans-retinoic acid (RA)-treated spina bifida rat fetus. MATERIALS AND METHODS: Timed-pregnant rats were gavage-fed RA, and embryos were obtained on 13.5, 15.5, 17.5, and 19.5 days. MicroRNAs' expression profile was analyzed by Northern blot. In situ apoptosis detection and microRNA in situ hybridization methods on sections of paraffin-embedded tissues were employed to explore the mechanism. CONCLUSION: Administration of RA reduced the size of the spinal cord, probably as a consequence of increased cell death. There is a dramatic decrease in the expression of miR-9/9*, miR-124a and miR-125b, and Bcl2 and P53 as well in the sacral cord from E13.5 to E19.5 days post coitum. Our data showed that expression of these microRNAs was dysregulated in RA-treated spinal cord during embryonic development, suggesting that they may be involved in the development of the spinal cord.
Authors: Antonio J Giraldez; Ryan M Cinalli; Margaret E Glasner; Anton J Enright; J Michael Thomson; Scott Baskerville; Scott M Hammond; David P Bartel; Alexander F Schier Journal: Science Date: 2005-03-17 Impact factor: 47.728
Authors: Lena Smirnova; Anja Gräfe; Andrea Seiler; Stefan Schumacher; Robert Nitsch; F Gregory Wulczyn Journal: Eur J Neurosci Date: 2005-03 Impact factor: 3.386
Authors: Erno Wienholds; Wigard P Kloosterman; Eric Miska; Ezequiel Alvarez-Saavedra; Eugene Berezikov; Ewart de Bruijn; H Robert Horvitz; Sakari Kauppinen; Ronald H A Plasterk Journal: Science Date: 2005-05-26 Impact factor: 47.728
Authors: Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos Journal: RNA Date: 2005-12-22 Impact factor: 4.942
Authors: Lorenzo F Sempere; Sarah Freemantle; Ian Pitha-Rowe; Eric Moss; Ethan Dmitrovsky; Victor Ambros Journal: Genome Biol Date: 2004-02-16 Impact factor: 13.583
Authors: Partha Mukhopadhyay; Guy Brock; Vasyl Pihur; Cynthia Webb; M Michele Pisano; Robert M Greene Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-07
Authors: Dana L Pappalardo-Carter; Sridevi Balaraman; Pratheesh Sathyan; Eric S Carter; Wei-Jung A Chen; Rajesh C Miranda Journal: Alcohol Clin Exp Res Date: 2013-06-25 Impact factor: 3.455
Authors: R Krishnan Kutty; William Samuel; Cynthia Jaworski; Todd Duncan; Chandrasekharam N Nagineni; Nalini Raghavachari; Barbara Wiggert; T Michael Redmond Journal: Mol Vis Date: 2010-08-04 Impact factor: 2.367